Swedish medical technology company PExA AB
(“PExA”) announced that it has entered into a research collaboration agreement with
Janssen Research & Development, LLC, one of the Janssen Pharmaceutical
Companies of Johnson & Johnson, and the University of Gothenburg.
biomarker discovery, was recently selected Awardee of the Carcinogenic Exposure Meter Quickfire Challenge. The Challenge was launched by Johnson & Johnson Innovation, the Lung Cancer Initiative (LCI) at Johnson & Johnson, and Janssen in an effort to help reduce the tobacco epidemic.
As part of the collaboration, Janssen will